http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Park, Taek Kyu,Hahn, Joo-Yong,Yang, Jeong Hoon,Song, Young Bin,Choi, Seung-Hyuk,Choi, Jin-Ho,Lee, Sang Hoon,Ahn, Joonghyun,Carriere, Keumhee Cho,Gwon, Hyeon-Cheol Europa Digital and Publishing 2017 EuroIntervention Vol.13 No.1
<P>Conclusions: Complete revascularisation of lesions with >70% diameter stenosis in vessels 22.5 mm is better than ICR, and is a reasonable goal for patients with multivessel disease.</P>
Park, Taek Kyu,Lee, Jae-Hwan,Song, Young Bin,Jeong, Jin-Ok,Hahn, Joo-Yong,Yang, Jeong Hoon,Choi, Seung-Hyuk,Choi, Jin-Ho,Lee, Sang Hoon,Jeong, Myung-Ho Europa Digital and Publishing 2016 EuroIntervention Vol.12 No.4
<P>Aims: Non-compliant balloons provide uniform radial force along the vessel wall at any inflation pressure. As a result, the use of non-compliant balloons may reduce side branch complications and optimise stent deployment. We sought to investigate the impact of non-compliant balloons on the long-term clinical outcomes of patients undergoing a coronary bifurcation intervention. Methods and results: A total of 2,897 patients treated with drug-eluting stents for bifurcation lesions were enrolled. Non-compliant balloons were used in 752 patients (26%). During a median three-year follow-up, major adverse cardiac events (MACE: cardiac death, myocardial infarction, or target lesion revascularisation) occurred less frequently in the non-compliant balloon group than in the compliant balloon group (8.2% versus 10.9%; p=0.03). After propensity score matching (710 pairs), the use of non-compliant balloons resulted in a lower rate of side branch dissection (0.1% versus 1.1%; p=0.046) and a higher rate of procedural success (79.0% versus 73.9%; p=0.01). The use of non-compliant balloons was associated with a lower risk of MACE (HR 0.64, 95% CI: 0.46-0.91; p=0.01) and cardiac death (HR 0.14, 95% CI: 0.03-0.64; p=0.01). Conclusions: The use of non-compliant balloons was associated with favourable procedural and long-term clinical outcomes in patients receiving coronary bifurcation intervention. ClinicalTrials.gov number: NCT01642992</P>